Methods for the diagnosis and treatment of acute lymphoblastic leukemia

The present invention relates to a method of treating acute lymphoblastic leukemia in a patient in need thereof comprising administering to the patient a therapeutically effective amount of an agent capable of inducing cell death of CCR8 expressing cancer cells. The present invention also relates to a method of diagnosing acute lymphoblastic leukemia in a patient comprising detecting the expression level of CCR8 in a sample obtained from the patient.

Keywords: acute lymphoblastic leukemia, diagnostic, Predictive, Compagnon diagnostic, CCR8
Patent Application number: European Procedure (Patents) (EPA) - 30 Juin 2022 - 22 305 958.5 and PCT/EP2023/067924 on 09/01/2024
Inventors:
BENSUSSAN ArmandORTONNE NicolasDE MASSON AdeleBAGOT MartineGIUSTINIANI JérômeLEMONNIER FrançoisSOULIER JeanGACHET StéphanieCLAPPIER Emmanuelle
Publications:
not published

Reference:

BIO22280-D1

Business Developper
contact
Inserm Transfert
Business Developer
Patent filling date: 30-06-2022
Rare disease: No
Second indication: No

You might also be interested in